Cardlytics (CDLX) Tops Q2 EPS by 10c, Revenues Beat
Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.12), $0.10 better than the analyst estimate of ($0.22). Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
